Associated Papers
Effect of genetic variations in drug transporters, metabolizing enzyme and regulatory genes on the development of HIV-associated lipodystrophy.
Shyamveer et al.
The Journal of Gene Medicine, 2023
Low High-Density Lipoprotein Cholesterol and High White Blood Cell Counts: A Mendelian Randomization Study.
Harsløf M et al.
Arteriosclerosis, Thrombosis, and Vascular Biology, 2021
CETP, LIPC, and SCARB1 variants in individuals with extremely high high-density lipoprotein-cholesterol levels.
Lee CJ et al.
Scientific Reports, 2019
Expression analysis of candidate genes for fatty acid composition in adipose tissue and identification of regulatory regions.
Revilla M et al.
Scientific Reports, 2018
Genetic determinants of inherited susceptibility to hypercholesterolemia - a comprehensive literature review.
Paththinige CS et al.
Lipids in Health and Disease, 2017
Elevated remnant cholesterol in 25-hydroxyvitamin D deficiency in the general population: Mendelian randomization study.
Ooi EM et al.
Circulation. Cardiovascular Genetics, 2014
Association of hepatic lipase gene polymorphisms with hypertriglyceridemia and low high-density lipoprotein-cholesterol levels among South Indian subjects without diabetes.
Ayyappa KA et al.
Diabetes Technology & Therapeutics, 2013
Gene-diet interactions on plasma lipid levels in the Inuit population.
Rudkowska I et al.
The British Journal of Nutrition, 2013
Remnant cholesterol as a causal risk factor for ischemic heart disease.
Varbo A et al.
Journal of the American College of Cardiology, 2013
Several genetic polymorphisms interact with overweight/obesity to influence serum lipid levels.
Yin RX et al.
Cardiovascular Diabetology, 2012
LCAT, HDL cholesterol and ischemic cardiovascular disease: a Mendelian randomization study of HDL cholesterol in 54,500 individuals.
Haase CL et al.
The Journal of Clinical Endocrinology and Metabolism, 2012
A Novel Mathematical Approach to Define the Genes/SNPs Conferring Risk or Protection in Sporadic Amyotrophic Lateral Sclerosis Based on Auto Contractive Map Neural Networks and Graph Theory.
Buscema M et al.
Neurology Research International, 2012
Hepatic lipase gene -514C>T variant is associated with exercise training-induced changes in VLDL and HDL by lipoprotein lipase.
Brinkley TE et al.
Journal of Applied Physiology (bethesda, Md. : 1985), 2011
Physical activity modifies the effect of LPL, LIPC, and CETP polymorphisms on HDL-C levels and the risk of myocardial infarction in women of European ancestry.
Ahmad T et al.
Circulation. Cardiovascular Genetics, 2011
Gene polymorphisms in APOE, NOS3, and LIPC genes may be risk factors for cardiac adverse events after primary CABG.
Eifert S et al.
Journal of Cardiothoracic Surgery, 2009
Hepatic lipase, genetically elevated high-density lipoprotein, and risk of ischemic cardiovascular disease.
Johannsen TH et al.
The Journal of Clinical Endocrinology and Metabolism, 2009
Hepatic lipase gene -514C/T polymorphism in the Guangxi Hei Yi Zhuang and Han populations.
Wu J et al.
Lipids, 2008
Association of an intronic haplotype of the LIPC gene with hyperalphalipoproteinemia in two independent populations.
Iijima H et al.
Journal of Human Genetics, 2008
Lipoprotein lipase 1595 c/g and hepatic lipase -480 c/t polymorphisms--impact on lipid profile in incident dialysis patients.
Chmielewski M et al.
Blood Purification, 2008
Genetic determinants of plasma lipoproteins.
Pollex RL et al.
Nature Clinical Practice. Cardiovascular Medicine, 2007
The C-480T hepatic lipase polymorphism is associated with HDL-C but not with risk of coronary heart disease.
McCaskie PA et al.
Clinical Genetics, 2006
Genetic variation in the hepatic lipase gene and the risk of coronary heart disease among US diabetic men: potential interaction with obesity.
Zhang C et al.
Diabetologia, 2006
Assessment of the role of genetic polymorphism in venous thrombosis through artificial neural networks.
Penco S et al.
Annals of Human Genetics, 2005
Polymorphisms affecting gene regulation and mRNA processing: broad implications for pharmacogenetics.
Johnson AD et al.
Pharmacology & Therapeutics, 2005
Hepatic lipase genotype, diabetes risk, and implications for preventative medicine.
Shuldiner AR et al.
The Journal of Clinical Endocrinology and Metabolism, 2004
Gene interactions and stroke risk in children with sickle cell anemia.
Hoppe C et al.
Blood, 2004
Effects of the hepatic lipase gene and physical activity on coronary heart disease risk.
Hokanson JE et al.
American Journal of Epidemiology, 2003
Genetic study of common variants at the Apo E, Apo AI, Apo CIII, Apo B, lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes and coronary artery disease (CAD): variation in LIPC gene associates with clinical outcomes in patients with established CAD.
Baroni MG et al.
Bmc Medical Genetics, 2003
Hepatic lipase: a marker for cardiovascular disease risk and response to therapy.
Zambon A et al.
Current Opinion in Lipidology, 2003
Influence of common variants in the CETP, LPL, HL and APO E genes on LDL heterogeneity in healthy, middle-aged men.
Skoglund-Andersson C et al.
Atherosclerosis, 2003
Loci for CETP, LPL, LIPC, and APOC3 affect plasma lipoprotein size and sub-population distribution in Hispanic and non-Hispanic white subjects: the Columbia University BioMarkers Study.
Humphries SE et al.
Nutrition, Metabolism, and Cardiovascular Diseases : Nmcd, 2002
Carotid intima-media thickness is associated with allelic variants of stromelysin-1, interleukin-6, and hepatic lipase genes: the Northern Manhattan Prospective Cohort Study.
Rundek T et al.
Stroke, 2002
Polymorphism of HL +1075C, but not -480T, is associated with plasma high density lipoprotein cholesterol and apolipoprotein AI in men of a Chinese population.
Fang DZ et al.
Atherosclerosis, 2002
A common promoter polymorphism in the hepatic lipase gene (LIPC-480C>T) is associated with an increase in coronary calcification in type 1 diabetes.
Hokanson JE et al.
Diabetes, 2002
Hepatic lipase gene -514 C/T polymorphism and premature coronary heart disease.
Ji J et al.
Journal of Cardiovascular Risk, 2002
Allele frequencies for candidate genes in atherosclerosis and diabetes among Trinidadian neonates.
Hegele RA et al.
Human Biology, 2001
Hepatic lipase promoter activity is reduced by the C-480T and G-216A substitutions present in the common LIPC gene variant, and is increased by Upstream Stimulatory Factor.
Botma GJ et al.
Atherosclerosis, 2001
Absence of association between genetic variation in the LIPC gene promoter and plasma lipoproteins in three Canadian populations.
Hegele RA et al.
Atherosclerosis, 1999
Hepatic lipase gene polymorphisms influence plasma HDL levels. Results from Finnish EARS participants. European Atherosclerosis Research Study.
Murtomäki S et al.
Arteriosclerosis, Thrombosis, and Vascular Biology, 1997